Yestle Kim

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Top Venues

Journal of medical economics

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Jesse Fishman, Yestle Kim, Helene Parise, Eric M Bercaw, Zachary Smith
Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis). Journal of medical economics 27 (1) (2024)
Jesse Fishman, Yestle Kim, Helene Parise, Eric M Bercaw, Zachary Smith
Budget impact of resmetirom for the treatment of adults with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis). Journal of medical economics (2024)
Jesse Fishman, Theresa Alexander, Yestle Kim, Iris Kindt, Patricia Mendez
A clinical decision support tool for metabolic dysfunction-associated steatohepatitis in real-world clinical settings: a mixed-method implementation research study protocol. Journal of comparative effectiveness research (2024)